621 POSTER A phase I study of combination therapy with AEE788, a novel multitargeted inhibitor of ErbB and VEGF receptor family tyrosine kinases, and RAD001, a mTOR inhibitor in recurrent GBM patients
Year: 2006
Type: conference-abstract
Authors: D. Reardon, T. Cloughesy, J. Rich, W. Yung, C. Cilea, W. Mietlowski, L. Yung, W. Chen, A. Lai, C. Conrad
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2019692199